Early-stage measurable residual disease dynamics and IGHV repertoire reconstitution during venetoclax and obinutuzumab treatment in chronic lymphocytic leukemia

Affiliations

• ¹ Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
• ² Department of Immunology, Erasmus MC, Rotterdam, the Netherlands.
• ³ Department of Hematology and Experimental Immunology, Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands.
• ⁴ Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
• ⁵ HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
• ⁶ Department of Hematology, Haga Hospital, The Hague, The Netherlands.
• ⁷ Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands. [email protected].